Click on a filter below to refine your search. Remove a filter to broaden your search.
An upcoming research program will examine the potential for telehealth and wearable sensors to address a specific primary progressive aphasia.
A light-therapy device for Parkinson’s that has been in the works since before the pandemic is now ready for a new trial, developers said.
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
A new blood test could provide an efficient and simple thumbs-up, thumbs-down method for screening for Alzheimer’s disease, researchers say.
Data from a smart watch could help predict Parkinson’s disease up to seven years before symptoms begin occurring, a new study shows.
An association was found for Alzheimer’s and Parkinson’s disease cases diagnosed before 60 years of age.
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Protective HLA-DRB1*04 subtypes bind strongly to aggregation-prone tau PHF6 sequence when acetylated at K311.
A researcher who builds passive AI-enabled monitoring devices believes that if more people adopted tech, it could provide invaluable data.
Wearable technologies, like smart watches and headbands, have engendered a new wave of studies on neurological disorders.